| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_41afc1b11cbae48ca90470f31ef17c0e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8240b00928c00406b9c64a48e3fe6d59
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_567b1e0c9d5905537fc43cabba955532 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-308
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-2821
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-285 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6896 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
| filingDate |
2020-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51a3216c7ccb2baa4547df00915b0cb0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6cbc57d76d8d8501d09e56ef1f11703f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_82787c0ee372fe85d858e4ad58c8d4c5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0cd7658aa816cb51b440eb2822af871
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1fb86a302d43faa16da49973f55ec0f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0e33930a1dbbbca26acde25cf8964b6c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_73ff8a39902792053a118ec3e16214c1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_59c9a3ae44dd34e48eeddedf8e444612 |
| publicationDate |
2022-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2022113320-A1 |
| titleOfInvention |
In vitro method for the diagnosis or prognosis of neurodegenerative disorders |
| abstract |
The present invention is focused on an in vitro method for the diagnosis or prognosis of neurodegenerative disorders. The method comprises measuring the level of expression or the concentration level of at least a lipoprotein receptor-related protein fragment (LRP fragment) or at least a lipoprotein receptor-related protein (LRP). |
| priorityDate |
2019-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |